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Abstract: 
 Mutation of Neuregulin-3 (Nrg3) results in defective embryonic mammary gland development. Here, 
we investigate functions of Nrg3 signalling in embryonic mammary morphogenesis. Nrg3 regulates 
the distribution of epithelial progenitor cells within the presumptive mammary-forming region during 
early mammary morphogenesis. Basal and suprabasal epithelial cells are significantly smaller within 
the hypoplastic mammary primordium that forms in Nrg3 mutants, indicative of failure to acquire 
mammary epithelial cell morphological phenotype. Activation of Erbb4 JM-a CYT-1, an Erbb4 
isoform expressed in the developing mammary primordium, leads to mammary epithelial cell 
spreading and migration. Nrg3 promotes the accumulation of epithelial progenitor cells at the 
mammary primordium site in embryo explant cultures. Our results implicate Nrg3 signalling in 
mediating key events of mammary mesenchyme specification, including mesenchymal condensation, 
mitosis, and induction of mammary marker expression. Taken together, our results show Nrg3 has a 
major role in conferring specification of the mammary phenotype to both epithelial and mesenchymal 
progenitor cells. 
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INTRODUCTION  
The mammary primordium (MP) consists of the primitive mammary epithelium and the 
adjacent mesenchyme [1]. Together these two tissues will direct the formation of the mammary gland 
during embryogenesis through a series of reciprocal interactions in which juxtacrine and paracrine 
signals are transmitted to mediate morphogenetic processes [2]. The mammary mesenchyme has 
inductive properties such that it can confer mammary fate to undifferentiated simple epithelium in 
tissue recombination experiments [3]. Based on these experiments, it is thought that during initial 
stages of embryonic mammary development, signals from the underlying mesenchyme provide an 
instructive signal to the overlying epithelium. The epithelium responds to the mesenchymal signal(s) 
by forming elliptically-shaped aggregates of epithelial cells which first appear on the ventral flanks of 
mouse embryos during embryonic day (E) E11 and five pairs of MP are morphologically distinct by 
E12 [4]. Several genetic pathways have been identified that are required during early embryonic MP 
development including Eda, Fgfs, Gli3, Nrg3, Pthrp, and Wnt signalling components [4,5]. 
Mechanistic insights into the precise cellular processes regulated by these genetic pathways are fairly 
limited and the genetic hierarchies among these key regulators remain to be completely clarified.  
The initial stages of mammary primordium 3 (MP3) formation fail to occur in Nrg3
ska
, 
hypomorphic mutants that express reduced Nrg3 levels. Our previous studies of Nrg3
ska
 mutants 
identified Nrg3 as a key mediator of mammary primordial specification, linking Nrg3 to the 
establishment of the mammary lineage during embryogenesis [6,7]. Nrg3 is expressed in the dermal 
mesenchyme underling the site where MP will subsequently form between E10.5-E11.25 [8]. When 
MP3 becomes morphologically distinct at ~E11.5, Nrg3 expression is found within the epithelium and 
is no longer expressed in the underlying mesenchyme [8].  Expression of Nrg3 throughout the 
epidermal progenitor cell compartment in K14-Nrg3 mice led to formation of supernumerary 
mammary gland formation, confirming a role for Nrg3 as a promoter of mammary cell fate during 
embryogenesis [7,9]. Dramatic alterations were also observed in postnatal K14-Nrg3 epidermis skin 
including changes in expression pattern of Tenascin C, an extracellular matrix protein of stem cell 
niches [9]. The receptor for Tenascin C, integrin β1, as well as integrin α6, a marker for epithelial 
progenitor cells, also showed perturbed expression in K14-Nrg3 epidermis, further suggesting a link 
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between Nrg3 signalling and progenitor cell regulation [9]. The cognate receptor of Nrg3, Erbb4 is 
expressed in dermal mesenchymal tissues of the mammary-forming region between E10.5-E11.0, 
before becoming strongly expressed in the surface epithelium of the site where the MP forms and 
remains expressed in the epithelium once MP3 has formed at E11.5 [8]. Erbb4 is alternatively spliced 
and exists as four major isoforms: JM-a CYT-1, JM-a CYT-2, JM-b CYT-1 and JM-b CYT-2 [10]. 
The Erbb4 isoforms regulate distinct aspects of postnatal mammary epithelial cell (MEC) and breast 
cancer behaviour including mammary cell differentiation, migration, proliferation and apoptosis [11-
13]. In fact, chemoattractant properties of Nrg3 and another Neuregulin member, Neuregulin-1 (Nrg1) 
have been demonstrated: both chemoattract interneuronal cells, a type of neural progenitor cell that 
expresses Erbb4 in the developing cerebral cortex/forebrain [14]. Ligands for the Erbb receptor 
tyrosine kinases, the Neuregulins, are compelling candidates to mediate early mammary 
morphogenesis due to their expression patterns in relevant MP tissues [8].  
Until recently, a lack of suitable reporter models existed for monitoring the early events 
occurring during MP formation. As a result, much remains to be understood regarding the cellular and 
molecular mechanisms by which the initial MP is developed from the simple epithelium. It has been 
clearly established that a very low level of cell proliferation is detected within the mammary 
primordial epithelium during the initial stages of organ formation from E11 through E14 stages 
[15,16]. Previous studies have concluded that early mammary morphogenesis is mediated primarily 
via localised cell movements [15,17]. Cell hypertrophy is also thought to contribute to increase in MP 
size [16]. It is not yet clear which signals mobilise the epithelial progenitors that are thought to locally 
migrate from along and near the mammary line to form the MP [1]. 
MP formation and initial organ growth appear to be elicited primarily through epithelial cell 
migration. We hypothesised that Nrg3 might facilitate epithelial progenitor movements in the 
presumptive mammary-forming region as the mammary primordium forms. We aimed to study the 
effects of Nrg3 and Erbb4 signalling on morphogenesis of embryonic mammary epithelium and 
mesenchyme, as well as cell migration and spreading of MECs. Here we show that Nrg3 has a major 
role in progenitor cell positioning and conferring specification of the mammary phenotype to both 
epithelial and mesenchymal progenitor cells. 
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MATERIALS AND METHODS 
Sample collection 
All animal work was carried out under UK Home Office project and personal licenses following local 
ethical approval and in accordance with local and national guidelines. TOPGAL mice (stock no. 4623) 
were purchased from the Jackson Laboratories. s-SHIP-GFP mice were kindly provided by the late 
Professor Larry Rohrschneider (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). 
 
Expression analyses 
Immunohistochemistry (IHC) and whole-mount immunofluorescence (WM-IF) of MP were 
performed as described [9,18]. Antibodies used for immunostaining were: GFP (clone FM264G) from 
BioLegend UK (London, UK); phospho-Ser10-Histone H3 (clone 3H10) from Millipore 
(Hertfordshire, UK); ERα from Santa Cruz Biotechnology (Dallas, TX, USA); Lef1 (clone C12A5) 
and Cleaved Caspase-3 (Asp175) from Cell Signaling Technologies (Danvers, MA, USA). Antibody-
labelled tissues were three-dimensionally analysed using Leica TCS SP II confocal scanning 
microscope as described [18]. Mitotic cells within control and Nrg3
ska
 MP3 were scored by manually 
counting phospho-Histone positive cells through confocal images of MP3 made every 1.5 µm. X-gal 
staining was performed as described [6]. Quantitative real-time RT-PCR (qRT-PCR) was performed 
on freshly extracted total RNA from total MP at E12.5, the microdissected components of the MP 
(ME, MM) and separated epidermis and mesenchyme. qRT-PCR was performed using the following 
Taqman Gene Expression Assay probes from Life Technologies (Paisley, UK): Actb 
(Mm00607939_s1), Esr1 (Mm00433149_m1), Ar (Mm00442688_m1), Pth1r (Mm00441046_m1) 
and Wnt10b (Mm00442104_m1). Results were analysed with the comparative Δ-ΔCt method 
normalised to Actb value and compared to comparator in triplicate. RT-PCR detecting Erbb4 isoforms 
Erbb4 JM-a/b and CYT-1/2 were performed as described [9]. 
 
Morphological analysis of MP 
GFP pictures of s-SHIP-GFP-expressing embryos at E11.5 and E12.5 were obtained on EVOS FL 
Color Imaging System from Life Technologies (Paisley, UK) using either x2 or x4 objectives. GFP 
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pictures were represented as black-and-white images to highlight where ME progenitor cells 
expressing s-SHIP-GFP accumulated on the embryo’s surface. Briefly, brightness/contrast and HDR 
toning in the raw images were adjusted using Adobe Photoshop CS5, and threshold was adjusted to 
display GFP-positive region of interest as black dots on a white background. Arrangement of MP 
along the ML was further assessed by measuring the angle of the line connecting MP1 to MP3 and 
MP3 to MP5 using ImageJ. To examine mammary cell morphology, cell borders were visualised 
using CellMask Orange Plasma Membrane Stain from Life Technologies (Paisley, UK). Briefly, 
WM-IF was performed on microdissected MP3 with a modified permeabilisation step using 1 mg/ml 
digitonin in PBS since detergents and methanol in general method are not compatible for the dye. The 
stained tissue was photographed three-dimensionally every 1.5 µm slice, using a confocal microscope 
equipped with x40 objective. To measure three-dimensional sphericity and volume of basal and 
suprabasal MEC, individual cell periphery was manually traced using plasma membrane stained 
images through each slice using the Contour Surface tool in Imaris software from Bitplane (Zurich, 
Switzerland). 
 
Recombinant proteins 
Mutagenised Nrg3, referred to as Nrg3mut is described in Rakic et al. [14]. Recombinant protein 
rNrg3-EGF wt and rNrg3-EGF mut were prepared in S2 Schneider cells as previously described [6]. 
Nrg1β-EGF (396-HB-050) and Wnt3a (1324-WN-010) were purchased from R&D systems 
(Minneapolis, MN, USA).  
 
Ex vivo culture of embryonic flanks 
Embryonic flanks from forelimb to hindlimb were carefully bisected from freshly isolated E11.0 
Nrg3
ska
 s-SHIP-GFP embryo in D-PBS (Life Technologies) taking care not to damage the epidermis 
around the presumptive mammary region. By monitoring GFP under fluorescent stereomicroscope, 
only intact Nrg3
ska
 flanks at a stage in which the MP had not formed yet were used for experiments. 
Flanks were placed in humidified centre-well organ culture dishes, Becton Dickinson, (Oxford, UK) 
equipped with polycarbonate filter membrane (P9699-100EA, Sigma) and culture medium at 37ºC 
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with 5% CO2. Freshly reconstituted EmbryoMax KSOM Embryo Culture media, Merck Millipore 
(Billerica, MA, USA) containing 75 µg/ml ascorbic acid (Sigma) was used. 2 µg/ml rNrg3-EGF or 
PBS was added to the media. After 24 hr incubation, the explants were evaluated for MP3 formation 
by GFP appearance and were fixed in 4% PFA in PBS and then subject to phospho-Histone staining 
which was used to score the number of mitotic cells in the mammary epithelial and mesenchymal 
tissues.  
 
Cell culture and transfection 
HC11 cells were maintained with RPMI1640 (Life Technologies) supplemented with 10% serum, 1% 
Penicillin/Streptomycin, 5 µg/ml Insulin (19278, Sigma), and 10 ng/ml human recombinant EGF 
(236-EG-200, R&D systems). To develop stable cell lines expressing isoform-specific Erbb4, 10 µg 
of human Erbb4 JM-a CYT-1 and JM-a CYT-2 cDNAs from expression constructs cloned in 
pcDNA3.1 were introduced using Amaxa Nucleofector II device and Cell Line Nucleofector kit V 
with a program T-024 (Lonza, Basel, Switzerland). After nucleofection, cells were maintained with 
media containing 1 mg/ml G418 (Life Technologies). After 2 weeks, a number of surviving colonies 
were tested for Erbb4 overexpression. Two independent clones were used for each isoform in this 
study: JM-a CYT-1 isoform, clone 5 and 6; JM-a CYT-2 isoform, clone 3 and 43.  
 
In vitro chemotactic assay 
Polycarbonate Membrane Transwell inserts (8 μm pore size, 24-well format) were coated with 50 
µg/ml rat tail Collagen type I (Becton Dickinson). HC11 cells expressing Erbb4 JM-a CYT-1 and JM-
a CYT-2 were treated with serum-free medium for 72 hr prior to the transwell migration assay. The 
starved cells were harvested using HyClone HyQtase cell detachment reagent from Thermo Scientific 
(Waltham, MA, USA) and resuspended to 4 x 10
5
 cells/ml with RPMI1640 supplemented with 1% 
serum, 1% BSA and 20 mM HEPES. 200 µl of cell suspension was added onto the Transwell inserts. 
The inserts were then transferred to 24-well plates filled with medium containing PBS, 2.0 µg/ml 
rNrg3-EGF wt, 1.0 µg/ml Nrg1β-EGF, or 0.01 µg/ml EGF. After 6 hr incubation, cells on the 
membrane insert were fixed with 4% PFA in PBS followed by DAPI staining. The transwell 
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migration was scored by counting the number of DAPI-labelled cells on the membrane at the bottom 
side. 
 
Cell adhesion staining and spreading assays 
0.5 x 10
5
 HC11 cells expressing Erbb4 JM-a CYT-1 or JM-a CYT-2 per well were placed on 
fibronectin-coated 12-well plate in culture medium overnight. Cells were incubated with serum-free 
medium prior to stimulation with growth factor. After 72 hr starvation, cells were treated for 15 min 
with serum-free medium containing PBS, 0.5 µg/ml rNrg3-EGF wt or mut, 0.2 µg/ml Nrg1β-EGF, 
and 0.05 µg/ml Wnt3a. Cells were immediately fixed with 4% PFA in PBS followed by staining for 
phospho-Tyr397-Focal adhesion kinase (p-FAK) from Cell Signaling Technologies, Alexa555-
Phalloidin and DAPI from Life Technologies. p-FAK-labelled cell adhesions were photographed 
using EVOS FL microscope equipped with x40 objective. Actin-based cell cytoskeleton and DAPI-
labelled nuclei were photographed using x10 objective. Segmented shape of cell and nucleus was 
abstracted and automatically measured using CellProfiler cell image analysis software 
(http://www.cellprofiler.org, Broad Institute, Cambridge, MA, USA). 5-95% percentile box and 
whiskers plots were generated using median, quartiles, highest and lowest values. 
 
Statistical analysis 
The data in the graphs are presented as mean and the standard error of the mean (SEM). The data 
were analyzed by two-tailed ANOVA or Student’s t-test using GraphPad Prism 6 software. P-
value<0.0001 is considered as extremely significant (****), p-value=0.0001 to 0.001 as highly 
significant (***), p-value=0.001 to 0.01 as significant (**), and ≥0.05 as not significant (ns), 
respectively.  
RESULTS  
Nrg3
ska
 mutants display aberrant distribution of epithelial progenitor cells along the 
presumptive mammary-forming region during early mammary gland morphogenesis 
We previously found that 55% of Nrg3
ska
 hypomorphic mutants fail to form mammary gland 
3 when mice were assessed for the presence or absence of nipples 7-10 days after birth [19]. We 
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backcrossed Nrg3
ska
 hypomorphic mutants and controls (C57Bl6/J) onto the s-SHIP-GFP reporter 
background, which expresses GFP in a subset of epithelial-lineage progenitor cells during embryonic 
development, including those present in the mammary-forming region [20]. We were then able to 
easily examine the formation of the MP between E10.5 and E12.5 since small aggregates of s-SHIP-
GFP+ cells are readily apparent at, and in the vicinity of, the sites where the MP form in controls 
(Fig. 1a,b). s-SHIP+ epithelial progenitor cells appear less focally distributed along the mammary-
forming region of Nrg3
ska
 hypomorphic mutants; more GFP+ cells remain on the dorsal-most aspect 
of the ventral flank when compared to control embryos in which a much denser ventral accumulation 
of GFP+ cells is observed at E11.5 (Fig. 1a). GFP+ cells observed along the mammary line fragment 
that corresponds to the site of MP3 formation appear to be shifted dorsally in Nrg3
ska 
compared to 
controls (Fig. 1a,b). These observations are further supported when changes in MP3 location were 
assessed by measuring the angles of the lines that connect MP1 to MP3, and MP3 to MP5 and 
compared them to those from control embryos and found this is significantly reduced in Nrg3
ska
 
embryos (Fig. 1c).  
Fewer s-SHIP-GFP+ cells are observed within the nascent Nrg3
ska
 MP3 when compared to 
control embryos at E12.5 (Fig. 1b). We restricted phenotypic analysis to MP3 since MP3 exhibits the 
most striking morphological defects in Nrg3
ska
 embryos. We found when E12.5-stage embryos are 
assessed for s-SHIP-GFP+ cell accumulation at the presumptive site of MP3, that 9% of Nrg3
ska
 
mutants fail to show any s-SHIP-GFP+ cell accumulation and were scored as aplastic; 37% form 
hypoplastic MP3 with substantial reduction in accumulation of s-SHIP-GFP+ cells and are greatly 
reduced in size, and the remaining 57% form a relatively-normal sized organ and were scored as 
MP3+ (Table S1). This variable phenotype permits analysis of the consequence of reduced Nrg3 
signalling in the epithelial progenitor cells of MP3 scored as either hypoplastic or MP3+ and the 
mesenchymal cells associated with them. 
 The s-SHIP-GFP reporter shows a similar expression pattern when compared to the 
TOPGAL-F reporter mouse [21] in both control and Nrg3
ska
 mutants between E10.5 and E12.5 (Fig. 
S1a). In Nrg3
ska
 mutants, fewer s-SHIP-GFP+ and TOPGAL+ cells accumulate along the mammary 
line fragment that spans the site of mammary MP3 formation. When profiled by qRT-PCR, Wnt10b, a 
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mammary line marker [22], is reduced in the epithelium isolated from hypoplastic Nrg3
ska
 MP3 
compared to control MP3 (Fig. S1b). Wnt10b expression is higher in the surface epithelium of the 
epidermis from the region dorsal to MP3 of Nrg3
ska
 embryos compared to control embryos, which is 
consistent with Wnt10b-positive epithelial progenitor cells remaining dispersed in the mammary-
forming region of Nrg3
ska
 embryos near MP3. These results suggest Nrg3 regulates s-SHIP+ and 
TOPGAL+ progenitor cells recruitment to form MP3. 
 
Maturation to achieve mammary epithelial cell phenotype fails in hypoplastic MP3 that form in 
Nrg3
ska
 mutants  
We used plasma membrane staining to assess epithelial cell morphology (Fig. 2a). Nrg3
ska
 
hypoplastic MP3 populations are composed of smaller epithelial cells when compared to control cells, 
which occupy larger volumes, but no significant change in cell sphericity is detected (Fig. 2b). 
Basally located cells show striking reductions in volume and suprabasal cells also show a significant 
reduction in cell volume in Nrg3
ska 
MP3 when compared to controls. Changes in sphericity are 
detected between basal and suprabasal cells, suggesting that morphological differentiation of the 
MECs is initiated, but does not mature to a full mammary phenotype, in Nrg3
ska 
MP3. We observed 
no changes in the number of apoptotic cells in hypoplastic Nrg3
ska
 and control MP3 epithelium when 
assessed by cleaved caspase-3 labelling (Fig. S2). Nuclear staining shows that epithelial multilayering 
is observed in MP3 of Nrg3
ska 
hypomorphic mutants (Fig. 2). We found no significant change in the 
number of mitotic cells observed in hypoplastic Nrg3
ska
 and control MP3 epithelium as assessed by 
phospho-Histone H3 staining (Fig. 3). It is notable that the surface epithelium has similar mitotic rate 
in Nrg3
ska 
hypomorphic mutants and control embryos (data not shown). Results from these 
morphometric analyses are consistent with our confocal and histological observations of the 
morphology of the cells present at the site of hypoplastic Nrg3
ska
 MP3 (Fig. 2, Figs S1, S2) and 
indicate Nrg3 mediates transitioning to the mammary epithelial phenotype. 
 
Nrg3
ska
 mutant MP3 display defective specification of mammary mesenchymal cells  
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Morphological analyses indicated that defects are also present in mesenchymal cells associated with 
Nrg3
ska
 MP3. The concentric rings of mesenchymal cells aligned around control MP3 epithelial cells 
start to appear at E12.5 but are not observed in mesenchymal cells adjacent to Nrg3
ska 
MP3 and these 
cells do not appear to condense (Figs 2-4). Lef1 stains both epithelial and mesenchymal MP3 control 
cells at E12.5 (Fig. 3c). We found that although Nrg3
ska 
MP3 are comprised of fewer epithelial cells 
compared to control MP3, Lef1 was expressed in Nrg3
ska 
MP3 epithelial cells. Lef1 expression was 
observed in mesenchymal cells adjacent to control MP3, but not in the mesenchymal cells associated 
with Nrg3
ska
 MP3. We also stained MP3 for expression of other mammary mesenchymal markers, 
including ER (Fig. 4a). We detected a reduced number of ER+ mesenchymal cells surrounding 
Nrg3
ska
 MP3 and lack of their condensation, even in those that are a similar size as control MP3 
(denoted MP3+); both are indicative of failed specification of mammary mesenchymal cells (Fig. 4a). 
Fewer mitotic cells are detected in Nrg3
ska
 mesenchymal cells associated with MP3 at E12.5 when 
compared to control (Fig. 3a,b). To ascertain if Nrg3 is required for the Pthrp/Pth1r-mediated 
specification of mesenchymal cells to a mammary phenotype to occur, we assayed levels of Pthrp and 
Pth1r, as wells as mammary mesenchymal markers ER and Ar, in RNA isolated from E12.5 
mammary primordial tissues. Using qRT-PCR, we found similar levels of Pthrp in epithelial cells 
from Nrg3
ska
 and control MP3 (data not shown). Mesenchymal cells surrounding the epithelium from 
aplastic and hypoplastic Nrg3
ska
 MP3, expressed the transcripts of ER, Ar, and Pth1r at significantly 
reduced levels compared to those from control MP3 and at levels more similar to those found in 
dermal mesenchymal cells and indicate failed mammary mesenchymal specification (Fig. 4b).  
 
Rescue of Nrg3
ska
 MP3 cultured with Nrg3 is not achieved through increasing epithelial mitotic 
activity 
When using conventional protocols that include serum-containing media for ex vivo culture of 
embryonic flanks, we observed a significant amount of epithelial proliferation within MP forming in 
culture (data not shown). We therefore optimised an ex vivo culture system using serum-free media so 
that it would mimic in vivo development where very little epithelial proliferation contributes to early 
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stages of MP development (Fig. 5a). Nrg3
ska
;s-SHIP-GFP ventral flanks were explanted at E11.0, 
prior to MP3 formation. Following 24 hours in culture ex vivo using these serum-free conditions, we 
assessed each Nrg3
ska
;s-SHIP-GFP ventral flank for the accumulation of s-SHIP-GFP+ cells at the 
site of MP3. We found that, 50% of the Nrg3
ska
;s-SHIP-GFP flanks formed MP3, whilst the 
remaining 50% were scored as having aplastic MP3. We found that when rNrg3-EGF was added to 
the culture media, after 24 hours in culture ex vivo, 87% of the explanted Nrg3
ska
;s-SHIP-GFP flanks 
formed MP3 and only 13% were scored as having aplastic MP3. No difference in the number of 
mitotic cells was observed in Nrg3
ska
;s-SHIP-GFP MP3 epithelial cells whether culture media 
contained rNrg3-EGF or not (Fig. 5b). In contrast, a significant increase in the number of mitotic cells 
was observed in the mesenchymal cells adjacent to MP3 epithelium when explants were cultured in 
media containing rNrg3-EGF compared to control media (Fig. 5b).   
 
MP selectively express cleavable Erbb4 JM-a Isoforms 
To further investigate the role of Nrg3 in facilitating the accumulation of epithelial progenitor 
cells at the site of MP3, we profiled the Erbb4 isoforms expressed during early embryonic mammary 
gland development by RT-PCR. We found that only the cleavable JM-a isoform is expressed and no 
JM-b isoform is detected in mid-gestation MP (Fig. 6a). Both CYT-1 and CYT-2 isoforms are 
expressed (Fig. 6a).  
 
MECs expressing Erbb4 JM-a CYT-1 isoform are more motile than cells expressing JM-a CYT-
2 isoform  
We transfected normal mouse mammary epithelial (HC11) cells with either the JM-a CYT-1 
or JM-a CYT-2 isoform of ERBB4 to create stable cell lines expressing the isoforms relevant to 
embryonic mammary development. Using transwell assays, we found that cells expressing JM-a 
CYT-1 were significantly more migratory than either HC11 cells expressing JM-a CYT-2 isoform, 
which exhibited minimal migratory ability that is comparable to levels detected with untransfected 
HC11 cells (Fig. 6b). Unstimulated HC11 cells expressing JM-a CYT-1 express activated full-length 
(180 kD) and cleaved (80 kD) forms of Erbb4 and activated Erbb2 (Fig. S3); these cells were slightly 
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more migratory when treated with either rNrg1β-EGF or rNrg3-EGF, ligands for Erbb4 (Fig. 6b). The 
effects of stimulating cells with rNrg3-EGF wt and rNrg3-EGF mut were evaluated by the levels of 
Erbb4 as well as Erbb2 phosphorylation as shown in Fig. S4. No increase in canonical Wnt signals 
was observed when HC11 cells expressing either JM-a CYT-1 or JM-a CYT-2 isoform were 
stimulated with rNrg3-EGF in TOPflash assays (Fig. S5).  These results indicate that Nrg3 does not 
increase canonical Wnt signals in MECs expressing either JM-a CYT-1 or JM-a CYT-2 isoform of 
Erbb4.  
 
Nrg3 promotes spreading of MECs expressing Erbb4 JM-a CYT-1 isoform 
To investigate the ability of Nrg3 to modulate MEC morphology, HC11 cells expressing 
either the JM-a CYT-1 or JM-a CYT-2 Erbb4 isoform were stimulated with rNrg3-EGF. Mammary 
cells expressing JM-a CYT-2 isoform showed no cell spreading in response to Nrg3 stimulation (data 
not shown). Mammary cells expressing JM-a CYT-1 isoform responded to both rNrg3-EGF and 
rNrg1β-EGF stimulation with a modest and significant amount of cell spreading (Fig. 7a-b). Cells 
expressing JM-a CYT-1 isoform treated with Wnt3A showed no cell spreading response, suggesting 
that growth factor-mediated cell spreading is specific for Erbb4-ligands in this cell type.  
 
MECs expressing Erbb4 JM-a CYT-1 isoform form focal adhesions after stimulation with 
rNrg3-EGF  
 Under non-stimulating conditions with rNrg3-EGF mut, JM-a CYT-1 expressing HC11 cells 
have sparse distribution of p-FAK rather than the large focal adhesions at actin bundles that are 
observed in HC11 cells and HC11 cells expressing JM-a CYT-2 (Fig. 7c). HC11 cells and HC11 cells 
expressing JM-a CYT-2 show no obvious response to stimulation with rNrg3-EGF wt, whereas large 
focal adhesions are formed in JM-a CYT-1 expressing HC11 cells after stimulation with rNrg3-EGF 
wt (Fig. 7c). HC11 cells expressing JM-a CYT-1 isoform show a discernible change in cell 
morphology after stimulation with rNrg3-EGF (Fig. 7c.) 
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DISCUSSION 
Alterations in epithelial progenitor cell distributions in Nrg3
 
hypomorphic mutants suggest 
that Nrg3 signals influence the behaviour of epithelial progenitor cell populations relevant to 
embryonic mammary development from E10.5 through E12.5. The failure of a signal that normally 
leads to s-SHIP-GFP progenitor cell aggregation along the mammary-forming region would explain 
the striking phenotypes observed uniquely with MP3 in Nrg3
ska
 mice [1]. The results presented here 
demonstrate the power of using the s-SHIP-GFP reporter model which permits analyses of epithelial 
progenitor cells through sequential developmental stages in situ using ex vivo embryonic cultures, 
which had not been previously possible for studies of embryonic mammary morphogenesis. Results 
from our embryo explant cultures in the s-SHIP-GFP reporter background strongly suggest Nrg3 
promotes epithelial progenitor aggregation as MP3 initially forms. We also demonstrate that Nrg3 
regulates epithelial progenitor accretion without increasing epithelial mitosis. The limited epithelial 
proliferation detected cannot account for the observed increases in mammary primordial size that 
occur between E10.5-E13.5 and that influx of cells from the adjacent surface epithelium accounts for 
the increases in epithelial cell numbers that accrue within the nascent organ [15-17]. Our results 
indicate Nrg3 signals mediate the distribution of epithelial progenitor cells along the ventral thoracic 
flank at the time that they are thought to be locally migrating to form the MP. A number of 
transcription factors including Gata3 and Tbx3 are required for the formation of all five pairs of MP, 
whilst others, such as Gli3 and Lef1, are only required for formation of certain MP, including MP3 
[23-27]. It is not yet clear precisely how the factors that regulate development of MP3 control 
epithelial progenitor cell distributions in the mammary-forming region, how these factors interact or 
whether any directly induce Nrg3 expression.  
Using 3-D morphometric analyses of MP3, we have quantified hypertophy that occurs in the 
epithelial progenitor cells within MP3 during maturation of the embryonic mammary epithelium. Our 
results indicate that Nrg3
ska
 MP3 cells achieve transition from cuboidal to columnar morphology, 
which normally occurs as the epithelium stratifies and during embryonic mammary development [25]. 
Further enlargement in size to acquire a mammary cell phenotype fails in Nrg3
ska
 MP3 cells. 
Defective epithelial hypertrophy is observed in Nrg3
ska
 MP3 and indicates Nrg3 mediates 
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transitioning to the mammary epithelial phenotype. Insufficient Nrg3 levels leads to formation of 
abnormal MP3 comprised of small aggregates of epithelial progenitor cells that have not fully 
differentiated to the mammary phenotype. Cell-based studies indicate Nrg3 promotes cell spreading 
and an ability to modulate cell morphology. Our results are consistent with a potential role for Nrg3 in 
promoting cell hypertrophy and contributing to initial organ growth via increase in cell area through 
cell spreading. However, it is not yet clear how Nrg3 elicits the columnar hypertrophy observed in 
vivo. 
Subsequent mammary mesenchymal specification is incomplete in Nrg3
ska
 MP3 as assessed 
by reduced mammary mesenchymal marker expression. This finding indicates that Nrg3-mediated 
mammary specification of epithelial progenitors cells also activates downstream effectors required for 
the transmission of signals from the mammary epithelial to adjacent mesenchymal cells. We also 
show that Nrg3 signalling increases proliferative potential of mammary mesenchymal precursor cells. 
Nrg3-mediated specification of the mammary epithelium is required for proliferation of the 
presumptive mammary mesenchymal precursor cells and their specification to a mammary 
mesenchymal phenotype to occur. 
Threshold levels of Nrg3 are likely to be required to form MP3 with fully specified mammary 
epithelial tissue capable of inducing Pth1r expression in the adjacent mesenchyme by some unknown 
mechanism. Sufficient Pth1r levels are required so stimulation of Pth1r by Pthrp leads to induction of 
mammary mesenchyme marker expression, including AR and ER [28], which show reduced 
expression in Nrg3
ska
 MP3. The Pthrp signalling axis is a master regulator of mammary mesenchymal 
specification which it mediates by activating canonical Wnt signaling in mesenchymal cells [28,29]. 
Similarities exist between Nrg3
ska
 and Pthrp-deficient MP with respect to their reduction in mammary 
mesenchymal marker expression and reduced proliferation of mammary mesenchymal cells. The 
mammary mesenchymal condensation defect observed in Nrg3
ska 
MP3 distinguishes its mesenchymal 
phenotype from that of Pthrp and Pth1r-deficient MP, which appear to undergo mesenchymal 
condensation [30]. We did not observe induction of Pth1r expression when mesenchymal tissues from 
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Nrg3
ska
 were cultured and treated with rNrg3 (data not shown) so Nrg3 does not appear to directly 
induce expression of Pth1r.  
Cell-based assays show that Nrg3 does not increase canonical Wnt signals in MECs 
expressing either JM-a CYT-1 or JM-a CYT-2 Erbb4 isoforms. Changes in expression of TOPGAL+ 
cells observed within the mammary-forming region of Nrg3
ska 
mice are unlikely to be due to Nrg3 
inducing canonical Wnt expression, but are consistent with Nrg3 stimulating migration and local 
aggregation of TOPGAL+ precursor populations at the site of MP3 but this remains to be formally 
demonstrated.  
MECs expressing the Erbb4 receptor of JM-a CYT-1 and JM-a CYT-2 show that these 
isoforms elicit distinct effects. CYT-1 and CYT-2, the cytoplasmic variants differ by the presence 
(CYT-1) or absence (CYT-2) of a short sequence containing a putative binding site for 
phosphatidylinositol (PI) 3-kinase p85 subunit [31]. In our studies, cells stably transfected with full-
length receptor for the JM-a CYT-1 isoform were significantly more migratory than those expressing 
JM-a CYT-2 isoform. Directional cell migration is regulated by assembly and turnover of integrin-
mediated adhesions [32]. Mammalian cells attach to surfaces through focal adhesions, cellular 
structures characterised by complexes of the transmembrane protein integrin and intracellular proteins 
including paxillin and focal adhesion kinase [33]. Since Erbb4 JM-a CYT-1 expression enhances 
migration ability in HC11 cells, we examined the effect of JM-a CYT-1 expression on cell adhesion 
formation, which was assessed with immunostaining with phospho-focal adhesion kinase (pFAK), a 
regulator of focal adhesion turnover. Under non-stimulating conditions, JM-a CYT-1 expressing 
HC11 cells display sparse distribution of p-FAK, rather than the large focal adhesions at actin bundles 
observed in HC11 cells and HC11 cells expressing JM-a CYT-2 (Fig. 7a). This data is in agreement 
with the observation that JM-a CYT-1 expressing cells are motile since migrating cells develop small 
adhesions rather than stabilised focal adhesions. MECs expressing JM-a CYT-1 isoform exhibit 
distinct responses to Nrg3 stimulation by forming focal adhesions and spreading, when compared to 
MECs expressing JM-a CYT-2 isoform, which show negligible changes in focal contacts and cell 
morphology after Nrg3 stimulation. These results suggest that Nrg3 stimulation affects cell adhesion 
dynamics and morphology, specifically for MEC cells expressing the JM-a CYT-1 isoform.  
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Divergent cellular responses by Erbb4 isoforms in MECs have previously been reported. 
Another study using inducible mouse models to express CYT-1 and CYT-2 isoforms in postnatal 
MECs showed that the ICD of these two isoforms exert opposing effects on the postnatal mammary 
epithelium when transgenically-expressed in vivo [12]. MECs from transgenic mice induced to 
express CYT-1 isoform were found to have decreased cell growth, increased lumen formation in 3-D 
culture, increased Stat5a activation, and precocious lactogenic differentiation when compared to non-
induced transgenic control postnatal mammary epithelium. Conversely, MECs from mice expressing 
transgenic CYT-2 isoform showed increased proliferation and no lumen formation in 3-D cultures 
compared to controls. The effect of expressing these isoforms on MEC migration was not explored in 
this study so it is not clear whether CYT-1 isoform has the ability to mediate migration of both 
embryonic and postnatal MECs. 
To conclude, we present evidence that Nrg3 promotes changes in cell adhesion dynamics and 
morphology of MECs and have identified a role for Nrg3 in promoting the maturation of the primitive 
mammary epithelium until it is fully specified to a mammary cell fate.  Nrg3 is likely to promote 
mammary epithelial aggregation through stimulation of the JM-a CYT-1 isoform of Erbb4. We 
propose a working model (Fig. 8) for the formation of MP3 in which Nrg3/Erbb4 signalling facilitates 
progressively maturation of epithelial progenitor cells until they achieve a fully specified mammary 
epithelial phenotype. This is achieved by Nrg3 promoting cell spreading using autocrine signals, 
which leads to cell hypertrophy, an event that coincides with maturation to acquire the mammary cell 
phenotype. Nrg3-mediated signals are needed to regulate condensation of mammary mesenchymal 
precursor cells, presumably by stimulating signal(s), which remain to be identified. Mesenchymal 
condensation may induce Pth1r expression in mammary mesenchyme precursors, which are then 
activated and undergo mammary mesenchymal specification. Mammary specification coincides with 
expression of mammary mesenchymal markers and cell population expansion through increased cell 
mitosis. In summary, we show Nrg3 signalling is required for both epithelial and mesenchymal 
mammary specification of embryonic progenitor cells. 
  
 20 
Acknowledgements 
We thank the Breakthrough Histopathology Facility for their assistance, the late Professor Larry 
Rohrschneider for s-SHIP-GFP mice and Professor Klaus Elenius for Erbb4 JM-a, CYT-1/CYT-2 
constructs. This research was funded by Breakthrough Breast Cancer. We acknowledge NHS funding 
to the NIHR Biomedical Research Centre. 
 
 
 
 
 
 21 
References 
1. Propper AY, BA Howard and JM Veltmaat. (2013). Prenatal morphogenesis of mammary 
glands in mouse and rabbit. J Mammary Gland Biol Neoplasia 18:93-104. 
2. Kratochwil K. Epithelium-mesenchyme interaction in the fetal mammary gland. (1988). 
Plenum Publishing Corporation. 
3. Cunha GR, P Young, K Christov, R Guzman, S Nandi, F Talamantes and G Thordarson. 
(1995). Mammary phenotypic expression induced in epidermal cells by embryonic mammary 
mesenchyme. Acta Anat (Basel) 152:195-204. 
4. Howard BA. (2012). In the beginning: the establishment of the mammary lineage during 
embryogenesis. Semin Cell Dev Biol 23:574-82. 
5. Cowin P and J Wysolmerski. (2010). Molecular mechanisms guiding embryonic mammary 
gland development. Cold Spring Harb Perspect Biol 2:a003251. 
6. Howard B, H Panchal, A McCarthy and A Ashworth. (2005). Identification of the 
scaramanga gene implicates Neuregulin3 in mammary gland specification. Genes Dev 
19:2078-90. 
7. Kogata N, M Zvelebil and BA Howard. (2013). Neuregulin 3 and Erbb Signalling Networks 
in Embryonic Mammary Gland Development. J Mammary Gland Biol Neoplasia 18:149-54. 
8. Wansbury O, H Panchal, M James, S Parry, A Ashworth and B Howard. (2008). Dynamic 
expression of Erbb pathway members during early mammary gland morphogenesis. J Invest 
Dermatol 128:1009-21. 
9. Panchal H, O Wansbury, S Parry, A Ashworth and B Howard. (2007). Neuregulin3 alters cell 
fate in the epidermis and mammary gland. BMC Dev Biol 7:105. 
10. Junttila TT, M Sundvall, JA Maatta and K Elenius. (2000). Erbb4 and its isoforms: selective 
regulation of growth factor responses by naturally occurring receptor variants. Trends 
Cardiovasc Med 10:304-10. 
11. Muraoka-Cook RS, SM Feng, KE Strunk and HS Earp, 3rd. (2008). ErbB4/HER4: role in 
mammary gland development, differentiation and growth inhibition. J Mammary Gland Biol 
Neoplasia 13:235-46. 
12. Muraoka-Cook RS, MA Sandahl, KE Strunk, LC Miraglia, C Husted, DM Hunter, K Elenius, 
LA Chodosh and HS Earp, 3rd. (2009). ErbB4 splice variants Cyt1 and Cyt2 differ by 16 
amino acids and exert opposing effects on the mammary epithelium in vivo. Mol Cell Biol 
29:4935-48. 
13. Jones FE. (2008). HER4 intracellular domain (4ICD) activity in the developing mammary 
gland and breast cancer. J Mammary Gland Biol Neoplasia 13:247-58. 
14. Rakic S, S Kanatani, D Hunt, C Faux, A Cariboni, F Chiara, S Khan, O Wansbury, B 
Howard, K Nakajima, M Nikolic and JG Parnavelas. (2013). Cdk5 Phosphorylation of ErbB4 
is Required for Tangential Migration of Cortical Interneurons. Cereb Cortex doi: 
10.1093/cercor/bht290. 
15. Balinsky B. (1949-1950). On the developmental processes in mammary glands and other 
epidermal structures. Transactions of the Royal Society Edinburgh 62:1-31. 
16. Lee MY, V Racine, P Jagadpramana, L Sun, W Yu, T Du, B Spencer-Dene, N Rubin, L Le, D 
Ndiaye, S Bellusci, K Kratochwil and JM Veltmaat. (2011). Ectodermal influx and cell 
hypertrophy provide early growth for all murine mammary rudiments, and are differentially 
regulated among them by Gli3. PLoS One 6:e26242. 
17. Balinsky BI. (1950). On the prenatal growth of the mammary gland rudiment in the mouse. J 
Anat 84:227-35. 
18. Kogata N and BA Howard. (2013). A Whole-mount Immunofluorescence Protocol for Three-
dimensional Imaging of the Embryonic Mammary Primordium. J Mammary Gland Biol 
Neoplasia 18:227-31. 
19. Howard BA and BA Gusterson. (2000). The characterization of a mouse mutant that displays 
abnormal mammary gland development. Mamm Genome 11:234-7. 
20. Rohrschneider LR, JM Custodio, TA Anderson, CP Miller and H Gu. (2005). The intron 5/6 
promoter region of the ship1 gene regulates expression in stem/progenitor cells of the mouse 
embryo. Dev Biol 283:503-21. 
 22 
21. DasGupta R and E Fuchs. (1999). Multiple roles for activated LEF/TCF transcription 
complexes during hair follicle development and differentiation. Development 126:4557-68. 
22. Veltmaat JM, W Van Veelen, JP Thiery and S Bellusci. (2004). Identification of the 
mammary line in mouse by Wnt10b expression. Dev Dyn 229:349-56. 
23. Hatsell SJ and P Cowin. (2006). Gli3-mediated repression of Hedgehog targets is required for 
normal mammary development. Development 133:3661-70. 
24. Boras-Granic K, H Chang, R Grosschedl and PA Hamel. (2006). Lef1 is required for the 
transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic 
mammary gland. Dev Biol. 
25. Veltmaat JM, F Relaix, LT Le, K Kratochwil, FG Sala, W van Veelen, R Rice, B Spencer-
Dene, AA Mailleux, DP Rice, JP Thiery and S Bellusci. (2006). Gli3-mediated somitic Fgf10 
expression gradients are required for the induction and patterning of mammary epithelium 
along the embryonic axes. Development 133:2325-35. 
26. Davenport TG, LA Jerome-Majewska and VE Papaioannou. (2003). Mammary gland, limb 
and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary 
syndrome. Development 130:2263-73. 
27. Asselin-Labat ML, KD Sutherland, H Barker, R Thomas, M Shackleton, NC Forrest, L 
Hartley, L Robb, FG Grosveld, J van der Wees, GJ Lindeman and JE Visvader. (2007). Gata-
3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. 
Nat Cell Biol 9:201-9. 
28. Hiremath M, P Dann, J Fischer, D Butterworth, K Boras-Granic, J Hens, J Van Houten, W 
Shi and J Wysolmerski. (2012). Parathyroid hormone-related protein activates Wnt signaling 
to specify the embryonic mammary mesenchyme. Development 139:4239-49. 
29. Hiremath M and J Wysolmerski. (2013). Parathyroid hormone-related protein specifies the 
mammary mesenchyme and regulates embryonic mammary development. J Mammary Gland 
Biol Neoplasia 18:171-7. 
30. Foley J, P Dann, J Hong, J Cosgrove, B Dreyer, D Rimm, M Dunbar, W Philbrick and J 
Wysolmerski. (2001). Parathyroid hormone-related protein maintains mammary epithelial 
fate and triggers nipple skin differentiation during embryonic breast development. 
Development 128:513-25. 
31. Elenius K, CJ Choi, S Paul, E Santiestevan, E Nishi and M Klagsbrun. (1999). 
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate 
phosphatidyl inositol 3-kinase. Oncogene 18:2607-15. 
32. Huttenlocher A and AR Horwitz. (2011). Integrins in cell migration. Cold Spring Harb 
Perspect Biol 3:a005074. 
33. Mitra SK, DA Hanson and DD Schlaepfer. (2005). Focal adhesion kinase: in command and 
control of cell motility. Nat Rev Mol Cell Biol 6:56-68. 
 
 
 23 
FIGURE LEGENDS 
Fig. 1. Nrg3
ska
 mutants display aberrant distribution of mammary epithelial progenitor cells 
during early mammary primordial morphogenesis.  
s-SHIP-GFP-expressing cells are shown visualised in whole-embryos. GFP-positive cells relevant to 
embryonic mammary gland development are indicated in black in the digitised images shown below 
the GFP images. The mammary line fragments and dorsal line are also visible with s-SHIP-GFP+ 
cells and indicated by red and green dotted lines, respectively.. 
a. At E11.5, s-SHIP-GFP+ cells in the vicinity of the level of ~somite 16/17 indicate the site where 
MP3 has formed in control (s-SHIP-GFP+; C57BL/6J) embryos. Compared to the control, alterations 
in distributions of s-SHIP-GFP+ epithelial progenitor cells at the site MP3 forms and along the 
thoracic mammary line fragment in Nrg3
ska 
embryos with hypoplastic MP3 and aplastic MP3 are 
displayed.  
b. At E12.5, s-SHIP-GFP+ cells indicate the sites where the 5 MP have formed in control embryos. 
The distribution of s-SHIP-GFP+ cells in Nrg3
ska 
embryos typically observed with hypoplastic MP3 
and aplastic MP3 are shown (Note that MP3 position in Nrg3
ska
 is dorsalised compared to the control). 
c. Angle between MP1-3 and MP3-5 were measured in control and Nrg3
ska
 embryos at E12.5 and 
E13.5. The horizontal lines in the graph indicate the mean value; n = between 11 to 25. **** indicates 
p-value<0.0001; ns indicates not significant (p=0.9268).  
FL, forelimb; HL, hindlimb; k, kidney; ml, mammary line (red dotted line); dl, dorsal line (green 
dotted line); 1, MP1; 2, MP2; 3, MP3; 4, MP4; 5, MP5. 
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Fig. 2. Morphological maturation and transition of surface epithelium to a mammary epithelial 
cell phenotype does not occur in MP3 of Nrg3
ska
 mutants. 
a. Confocal images of MP3 at E11.5 and E12.5 from control and Nrg3
ska
 embryos visualised with 
DAPI (nuclei) and plasma membrane stain (cell border). MP cells marked as red indicate suprabasal 
cells, blue indicate basal cells. Epithelial-mesenchymal boundary is indicated by yellow dotted line. A 
heterogeneous population of cells is obvious in mammary epithelium from E11.5 onward, which 
includes columnar cells marked with blue ovals. Early epithelial multilayering is observed in MP3 of 
Nrg3
ska 
hypomorphic mutants at E11.5-stage but these cells do not progressively mature to a 
mammary cell phenotype observed in control embryos at E12.5. Scale bar is 50 µm. 
b. Three-dimensional images were generated using Imaris software, which was used to quantify cell 
sphericity and volume of mammary epithelial cells in Nrg3
ska
 and control MP3 at E12.5. Values 
calculated with this software for individual cells are shown in graphs. The horizontal lines in the 
graph indicate the mean value, n = 10. Scale bar is 50 µm.  
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Fig. 3. Nrg3
ska
 mutants display impaired mammary mesenchymal proliferation. 
a. Expression of phospho-Histone H3 (red) in E12.5-stage control and Nrg3
ska 
MP3. Scale bar 50 m. 
b. Mitotic cell numbers three-dimensionally detected in epithelial and mesenchymal cells in control 
and Nrg3
ska 
MP3. ME, mammary epithelium; MM, mammary mesenchyme. n = between 7 to 8. 
c. Expression of Lef1 (white) in E12.5-stage control and Nrg3
ska 
MP3. Enlarged image (bottom) 
highlights reduced Lef1 expression observed in Nrg3
ska 
mesenchymal cells adjacent to MP3 
epithelium compared to those of control mesenchymal cells, whilst Nrg3
ska
 MP3 epithelium has Lef1 
expression level comparable to control epithelium. Epithelial-mesenchymal boundary is indicated by 
yellow dotted line. Scale bar 50 m. 
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Fig. 4. Nrg3
ska
 mutants display defective specification of mammary mesenchyme. 
a. Expression of ER (red in top and white in bottom panel), s-SHIP-GFP (green) in E12.5-stage 
control and Nrg3
ska 
MP3. Mammary mesenchymal marker ER-expressing cells are reduced in 
Nrg3
ska
 MP3.  Scale bar 50 m. Epithelial-mesenchymal boundary is indicated by yellow dotted line. 
b. Results showing relative fold expression levels of Esr1, Ar, and Pth1r as assayed by qRT-PCR of 
mesenchymal tissues surrounding Nrg3
ska
 and control MP3 and adjacent dermal mesenchyme when 
normalised to mammary mesenchyme in control MP3. MM, mammary mesenchyme. 
 
 27 
Fig. 5. Formation of MP3 in Nrg3
ska
 mutants can be restored by rNrg3-EGF treatment ex vivo 
without increasing epithelial mitosis and is associated with stimulation of mammary 
mesenchymal mitosis. 
a. s-SHIP-GFP expression of E11.0-stage Nrg3
ska
 flanks before starting culture (Day 0). The same 
flanks photographed 24 hours after ex vivo culture in serum-free media with PBS or with rNrg3-EGF 
added to media (Day 1). The % of flanks that do not form MP3 (Aplastic MP3) or do form MP3 (MP3 
formed) after 24 hours of ex vivo culture is indicated below an image depicting a representative result 
for the two outcomes in both treatment groups. n = 46 to 52. 
b. Mitotic cell numbers detected in epithelial and mesenchymal cells of MP3 that form 24 hours after 
ex vivo culture of Nrg3
ska
 flanks in serum-free media with PBS or with rNrg3-EGF. n = 20 to 22. 
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Fig. 6. Expression of Erbb4 JM-a CYT-1 isoform enhances migration of HC11 cells. 
a. E12.5-stage whole-embryos were used as a positive control (p.c.) that express four isoforms of 
Erbb4. Only cleavable JM-a Erbb4 isoforms are expressed in the embryonic MP. RT-PCR data 
indicates that JM-a, CYT-1 and CYT-2 isoforms are expressed during initial stages of mammary 
morphogenesis. 
b. Results from transwell migration assays show that HC11 cells expressing the JM-a CYT-1 isoform 
(clone 5 and 6) are more motile than cells expressing JM-a CYT-2 isoform (clone 3 and 43) and 
migrate very slightly in response to Erbb4 ligands, Nrg1β and Nrg3. Significance is shown in 
comparison with HC11 samples. 
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Fig. 7. Nrg3 promotes cell spreading and focal adhesion formation of HC11 cells expressing 
Erbb4 JM-a CYT-1 isoform.  
a. Cell area of HC11/JM-a CYT-1 cells treated with PBS or rNRG3-EGF for 15 minutes as visualised 
with Phalloidin (red) and DAPI (blue) stain. Digitised images used for quantification are shown below 
with the cell border marked in white and nucleus circles in green. Scale bar is 100m. 
b. Cell area of HC11/JM-a CYT-1 cells measured after 15-minute stimulation with PBS, mutant 
rNRG3-EGF, rNRG3-EGF, rNRG1-EGF or Wnt3A. 5-95% percentile box and whiskers plots were 
generated using median, quartiles, and highest and lowest values. Median values are indicated. 
Significance is shown in comparison with PBS samples. 
c. Cell adhesions in control HC11 and HC11 cells expressing Erbb4 isoform are visualised by 
phospho-tyrosine 397-FAK (pFAK) labelling together with phalloidin staining. Under non-
stimulating conditions with a mutated rNrg3-EGF (rNrg3-EGF mut), HC11 cells expressing Erbb4 
JM-a CYT-1 appear to have a smaller number of large focal adhesions linked to actin bundles that 
appear prominently in both HC11 cells and HC11 cells expressing Erbb4 JM-a CYT-2 (Arrowheads). 
Focal adhesions appear in HC11cells expressing Erbb4 JM-a CYT-1 after cells are stimulated with 
rNrg3-EGF wt (Arrows). Scale bar is 100m. 
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Fig. 8. Model for Nrg3/Erbb4 signalling in mammary epithelial and mesenchymal specification. 
Nrg3 expression within the nascent mammary primordial epithelial cells from E11.5 onward leads to 
changes in morphology of Erbb4 JM-a CYT-1-expressing mammary progenitor cells, resulting in an 
increase in cell volume and mammary cell phenotype acquisition. At E12.0, Nrg3-mediated signals 
are transmitted from the mammary primordial epithelium to adjacent mesenchymal cells, leading to 
their condensation by mechanisms that remain to be identified. Either Nrg3-mediated condensation or 
other signals lead to Pth1r expression in adjacent mesenchymal cells. Mesenchymal cells can then 
respond to activation of Pth1r, which specifies mammary cell fate to mesenchymal progenitors and 
leads to their differentiation (MM marker expression) and increased mitosis. 
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